CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
AbClon Inc Company Snapshot
AbClon Inc operates in the Biological products exc. diagnostic sector. In addition to historical fundamental analyses, the complete report available to purchase compares AbClon Inc with three other companies in this sector in KOREA (SOUTH) : Helixmith Co Ltd (2020 sales of 4.30 billion Korean Won [US$3.85 million] of which 436% was Drug Medicine Research and Development), Ensol Biosciences Inc (588.45 million Korean Won [US$526,664.97 ] of which 100% was Pharmaceutical Development and Sales), and Peptron Inc (3.12 billion Korean Won [US$2.79 million] of which 54% was Biotechnology).

Sales Analysis. During the first quarter of 2021, sales at AbClon Inc totalled 568.34 million Korean Won . This is a drop of 33.7% from the 857.17 million Korean Won in sales at the company during the first quarter in 2020. Sales fell dramatically in 2020: AbClon Inc reported sales of 2.77 billion Korean Won (US$2.48 million) for the year ending December of 2020. This represents a sharp decrease of 80.7% versus 2019, when the company's sales were 14.38 billion Korean Won . Contributing to the drop in overall sales was the 96.8% decline in Royalty, from 11.50 billion Korean Won to 363.75 million Korean Won . There were also decreases in sales in Service (down 24.0% to 1.58 billion Korean Won ) . However, these declines were partially offset by the increase in sales of Merchandise (up 3.8% to 831.19 million Korean Won ) .
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
AbClon Inc
  Stock Performance Chart for AbClon Inc
 
  Stock Data: Recent Stock Performance:
  Current Price (6/11/2021): 22,550
(Figures in Korean Won )
1 Week -6.6%   13 Weeks -4.4%  
4 Weeks -26.7%   52 Weeks -37.2%  
 
AbClon Inc Key Data:
  Ticker: 174900 Country: Korea (South)
  Exchanges: SEO Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Biological Products Exc. Diagnostic
  2020 Sales 2,771,179,187
(Year Ending Jan 2021).
Employees: 50
  Currency: Korean Won Market Cap: 344,520,455,950
  Fiscal Yr Ends: December Shares Outstanding: 15,278,069
  Share Type: Common Closely Held Shares: 2,626,708
 
 
Sponsored Links
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.